- Methodology article
- Open Access
Translocation of signalling proteins to the plasma membrane revealed by a new bioluminescent procedure
- Carlotta Giorgi†1, 2, 3,
- Anna Romagnoli†2,
- Chiara Agnoletto1,
- Leda Bergamelli2,
- Giovanni Sorrentino2,
- Marisa Brini4,
- Tullio Pozzan5, 6,
- Jacopo Meldolesi3,
- Paolo Pinton1Email author and
- Rosario Rizzuto5Email author
© Giorgi et al; licensee BioMed Central Ltd. 2011
- Received: 7 December 2010
- Accepted: 9 June 2011
- Published: 9 June 2011
Activation by extracellular ligands of G protein-coupled (GPCRs) and tyrosine kinase receptors (RTKs), results in the generation of second messengers that in turn control specific cell functions. Further, modulation/amplification or inhibition of the initial signalling events, depend on the recruitment onto the plasma membrane of soluble protein effectors.
High throughput methodologies to monitor quantitatively second messenger production, have been developed over the last years and are largely used to screen chemical libraries for drug development. On the contrary, no such high throughput methods are yet available for the other aspect of GPCRs regulation, i.e. protein translocation to the plasma membrane, despite the enormous interest of this phenomenon for the modulation of receptor downstream functions. Indeed, to date, the experimental procedures available are either inadequate or complex and expensive.
Here we describe the development of a novel conceptual approach to the study of cytosolic proteins translocation to the inner surface of the plasma membrane. The basis of the technique consists in: i) generating chimeras between the protein of interests and the calcium (Ca2+)-sensitive, luminescent photo-protein, aequorin and ii) taking advantage of the large Ca2+ concentration [Ca2+] difference between bulk cytosolic and the sub-plasma membrane rim.
This approach, that keeps unaffected the translocation properties of the signalling protein, can in principle be applied to any protein that, upon activation, moves from the cytosol to the plasma membrane.
Thus, not only the modulation of GPCRs and RTKs can be investigated in this way, but that of all other proteins that can be recruited to the plasma membrane also independently of receptor activation.
Moreover, its automated version, which can provide information about the kinetics and concentration-dependence of the process, is also applicable to high throughput screening of drugs affecting the translocation process.
- Light Emission
- Protein Translocation
- pcDNA3 Vector
Translocation of proteins, from the bulk of the cytosol to the plasma membrane, is a critical step in the transfer of information from membrane-embedded receptors to the cell interior. Just to cite a few examples, both RTKs and GPCRs recruit, upon activation, effector proteins such as SH2-containing adaptor proteins , various enzymes and the desensitizing proteins arrestins . In addition, other classes of effector proteins, such as those of the broad protein kinase C family , are activated upon translocation to the plasma-membrane microenvironment, independently of receptor binding. Detailed knowledge of the translocation of specific proteins, not only in physiological, but also in pathological conditions, may therefore highlight key aspects of defined signalling pathways. Impaired or excessive translocations of specific proteins are known in fact to play important roles in the pathogenesis of diseases (see for example the case of the beta 2 isoform of protein kinase C, PKCβII, in hyperglycemia and vascular complications of diabetes mellitus [4, 5]).
In the past, the classical approaches employed to investigate translocation were immunocytochemistry and subcellular fractionation followed by western blotting of the isolated fractions. Although adequate to reveal the existence of the process these approaches suffered of many drawbacks and limitations: possible artefacts, low time and space resolution, low sensitivity, problems in the precise identification of the cellular structures involved, that have limited their use to the low-throughput investigation.
The introduction of GFP fluorescent probes and, more recently, of the restoration of the β-galactosidase activity following complementation of two inactive fragments of the enzyme , has made possible the kinetics of protein translocation to be investigated in living cells. However, with GFP probes the increases in fluorescence are relatively small, often mixed up by the interference of endogenous fluorophores. The novel β-galactosidase complementation procedure is intrinsically complex. Two chimeric reporters, the translocating protein and its specific target, localized in a precise subcellular structure, are necessary. The translocation process is inevitably influenced by the binding of the two fragments and the proteins addressed to unknown targets cannot be investigated, limiting this technique for a screening purpose.
Here we report results obtained by following the translocation of two interesting proteins (Figure 1C): β-arrestin-2 (βarr2), addressed to a precise receptor target; and PKCβII, for which no protein target is known in the plasma membrane. By the use of a robot the procedure could be made more powerful, providing information about specific aspects of the translocation process, including its time-course and the dose-dependence of its activation.
Generation of chimeric probes
Cohesive cDNA constructs, encoding aequorin and β-arrestin-2 or PKCβ were fused in frame and the reporter chimeric proteins are denominated βarr2-AEQ and PKCβ-AEQ (Figure 1C), respectively.
In resting cells βarr2-AEQ exhibited a diffuse cytoplasmic distribution (Figure 2A, upper images); upon isoprenaline addition the chimera was rapidly (within 1 min) translocated to the periphery, however only in the cells transfected with the β2AR (see the bottom right image of Figure 2A). The stimulation time chosen for the luminescence assays with this chimera was therefore of 1 min.
Other batches of HeLa cells were transfected with the PKCβII-AEQ cDNA and treated with phorbol 12-myristate 13-acetate (PMA), a potent activator of classical PKCs . In this case, the translocation of the probe, from its diffuse distribution at rest to a peripheral distribution, required less than 5 min of PMA treatment (1 μM, Figure 2B).
These times match those reported previously for the translocations of the two proteins upon the two types of stimulation. Thus, the aequorin tag does not affect the activity-dependent translocation of either investigated protein.
Analysis of βarr2-AEQ and PKC-AEQ translocation by luminescence assay
The possibility of randomly developing thousands of new drugs by combinatorial chemistry, and to rapidly develop lead compounds, represents an immense value in pharmaceutical research. To take full advantage of this technological potential, however, screening methodologies must be available that are robust, reproducible and amenable to medium/high throughput applications. In some cases (see the analysis of Ca2+ homeostasis), the tools commonly employed in basic research, the intracellularly trappable fluorescent dyes, such as fura-2 or Fluo-3, proved highly effective in high-throughput screenings, and are commonly employed for the development of the vast array of drugs acting on Ca2+ signalling . These probes, however, can monitor one of the earliest events following receptor activation, but the data thus obtained are difficult to interpret for the understanding of other downstream signalling processes: protein translocation to the plasma-membrane is a typical example: it is a signalling step common to many diverse pathways (from RTKs and GPCRs, to the activation of specific enzymatic effectors) [14–17], but the currently available probes and techniques do not allow wide-range screenings or require complex and error-prone data analyses.
In this contribution, we have developed a novel approach that utilizes a Ca2+ sensitive photoprotein, aequorin, for a task different from the measurement of calcium signalling itself, and stems from an experimental observation and a technical aspect. The first is the measurement of the [Ca2+] in the thin rim of cytoplasm beneath the plasma membrane, where both at rest and in particular upon stimulation the flow of Ca2+ from the extracellular medium produces a local [Ca2+] that is at least one order of magnitude higher than in the deeper, bulk cytosol . Thus, aequorin can act as a tag of protein translocation, as the simple movement of the tagged protein to the plasma membrane markedly changes the [Ca2+] to which it is exposed. The second startpoint of the new methodology is an intrinsic property of the photoprotein, i.e. the logarithmic correlation between [Ca2+] and light emission . This property, that greatly increases light output with relatively small [Ca2+] increases, represents in most cases an experimental concern, as it tends to amplify the contribution of highly responding cells or cell domains in signalling studies. In the case of the new methodology reported in this paper, the high reponsiveness of the photoprotein represents a major plus, as it allows to detect protein translocation (e.g. a cytosolic adapter of the plasma membrane receptor) also when only a fraction of the protein actually moves within the cell. Together with the other advantages of a luminescence-based probe (no background signal, for the lack of other luminescent molecules within the cell, the simple geometry of the detection apparatus, etc.), this property provides a striking advantage over existing methodologies (GFP-based translocation assays, immunoblotting of subcellular fractions, etc.).
We have thus developed aequorin-based probes, that allow to detect the translocation of two classes of signalling proteins, a receptor adapter (β-arrestin, recognizing all classes of GPCRs)  and an important enzyme transducer, a member of the broad and complex family of PKC . The engineered probes, βarr2-AEQ and PKCβ-AEQ were uniformly distributed in the cytosol at rest, and translocated to the plasma membrane upon stimulation with suitable compounds (isoprenaline and PMA respectively), triggering a dramatic increase in aequorin photon emission. In both cases, the probes proved very effective also with automated multi-well detectors. For β-arrestin, the pharmacological characterization of a receptor agonist proved its reliability, not only in the identification of active compounds, but also in the complete assessment of its functional properties.
Overall, the understanding of the subcellular heterogeneity of Ca2+ homeostasis and the experience with a recombinant luminescent Ca2+ probe has allowed us to develop a robust, highly reproducible methodology for monitoring, in research applications and screening platforms, the translocation of specific proteins to the plasma membrane. This innovation will allow deciphering, and pharmacologically tackling, a critical step in a wide variety of signalling pathways including the whole complement of GPCRs and RTKs and kinases recruited to the plasma membrane independently of receptor activation [16, 17]. This cellular assay, based on a single reporter protein and the unique single-to-noise ratio of the luminescent probe, meets the expanding demand for cost-effective screening procedures. It may therefore prove a highly valuable tool for identifying new blockbuster drugs in compound libraries of thousands of chemicals.
Plasmids and sequences
The sequence coding for the bovine β-arrestin-2 protein was a gift of dr. V. Schiaffino (Milan, Italy). The cDNA was amplified with the following primers: forward, 5'-GGGTACC GCCACCATGGGGGAGAAACCC-3' (KpnI site underlined); reverse, 5'-GAAGCTT CATGCAGAACTGGTCGTC-3' (HindIII site underlined), and then subcloned in the pSCA vector (StrataClone™). The sequence was excised from the pSCA vector and inserted in frame upstream of the cDNA coding for aequorin protein into the pcDNA3 vector, previously cut KpnI-HindIII.
The sequence coding for the β2 adrenergic receptor was amplified with the following primers: forward, 5'-GCGGCCGC GCCACCATGGGGCAACCCGGGAA-3' (NotI site underlined); reverse, 5'-CCGGATTC CGGTTACAGCAGTGAGTCATTTGTAC-3' (BamHI site underlined), subcloned in the pSCA vector and finally cloned into the pcDNA3 vector previously cut EcoRI. cyt-AEQ , and aequorin targeted to the subplasmamembrane region, SNAP-AEQ  were generated as previously described.
The PKCβII-AEQ probe was constructed cloning upstream the aequorin cDNA in pcDNA3 vector, previously cut KpnI, the sequence coding for the PKCβII, excised KpnI from the chimera PKCβII -GFP, present in our laboratories .
Cell culture and transfection
HeLa cells were grown in Dulbecco's modified Eagle's medium (DMEM), supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 0.25 mg/l benzylpenicillin solution, 10 U.I./I streptomycin solution. For aequorin measurements 50,000 cells were seeded either in 24-well plate Falcon or onto 13 mm glass coverslips; for immunofluorescence detection 100,000 cells were seeded on 24 mm glass coverslips. At 50% confluence the cells were transfected using the calcium-phosphate technique:
- media was replaced on each well, 1 h before transfection, with 1 or 2 ml of fresh media (DMEM + 10% FBS + pen/strep)
- cells were transfected using 4 ug (13 mm or 24 well) or 8 ug (24 mm) of total DNA
- day after medium was replaced and experiments were performed 36 h after transfection.
Cells, seeded onto 24 mm coverslips, were transiently transfected with a total amount of 8 μg of the appropriate plasmid DNAs (βarr2-AEQ and β2AR/empty vector in a 1:3 ratio or PKCβII-AEQ alone). 36 h after transfection cells were stimulated with isoprenaline (40 μM, 1 min) or PMA (1 μM, 5 min), washed twice in PBS and fixed for 20 min with 4% paraformaldehyde in PBS at room temperature, supplemented with quenching solution (0.1 M glycine in PBS) for 10 min, washed and permeabilized with 0.2% Triton X-100 for 20 min, rinsed three times with PBS and incubated for 90 min with 2% BSA in PBS to block nonspecific binding sites. The proteins of interest were identified with primary polyclonal rabbit anti-arrestin IgG (1:500, Calbiochem, UK) or a monoclonal mouse anti-PKCβII (1:200, Santa-Cruz Biotec., CA, USA) antibodies in PBS, 2% BSA, incubated overnight at 4°C in a wet chamber and revealed with the AlexaFluor 594 anti-rabbit and anti-mouse antibodies (Invitrogen, Molecular Probes, CA, USA), respectively, diluted at 1:1000 in PBS, 2% BSA. After washing, the cells were imaged with a Zeiss LSM 510 Confocal Laser Scanning Microscope (Carl Zeiss, Jena, Germany).
Aequorin assay with single-well luminometer
Cells were transfected with a total amount of 4 μg of the appropriate plasmid DNAs (βarr2-AEQ/cyt-AEQ/SNAP-AEQ and β2AR in a 1:3 ratio or PKCβII-AEQ/cyt-AEQ/SNAP-AEQ alone). In order to potentiate Ca2+ influx and thus Ca2+ level just beneath the plasma membrane, 36 h after transfection cells were incubated for 1 h at 37°C, in KRB/EGTA (Krebs-Ringer modified buffer: NaCl 125 mM, KCl 5 mM, Na3PO4 1 mM, MgSO4 1 mM, glucose 5.5 mM, HEPES 20 mM, pH 7.4/EGTA 100 μM,) supplemented with 5 μM coelenterazine for aequorin reconstitution. Cells were then stimulated with isoprenaline 40 μM for 1 min or PMA 1 μM for 5 min and light emission was measured restoring Ca2+ to the extracellular medium perfusing cells with KRB plus 1 mM CaCl2. To terminate the experiments and discharge the remaining aequorin, the medium was replaced with a water solution containing 100 μM digitonin and 10 mM CaCl2. All results are expressed as mean ± standard error (SE).
Aequorin assay with automated luminometer
After the transfection and reconstitution procedures, isoprenaline 40 μM was added for 1 min before putting the multi-well plate in the instrument (MicrobetaJET, PerkinElmer, CA, USA). KRB supplemented with 2 mM CaCl2 was then injected and luminescence was recorded for 60 s. To terminate the experiments and discharge the remaining aequorin, a water solution containing 500 μM digitonin and 50 mM CaCl2 was injected.
To follow the kinetics of βarr2-AEQ translocation, isoprenaline 40 μM was added at the KRB/Ca2+ injected. To generate the concentration response curve, cells were treated with increasing concentration of isoprenaline (0.1-100 μM). All results are expressed as mean ± standard error (SE).
We thank Michelangelo Campanella, Patrizia Pellegatti and Denis Ottolini for carrying out some experiments. This research was supported in part by the Italian Ministry of Education, University and Research, the European Union (FP7 "MyoAGE"), the Italian Space Agency, the NIH (Grant #1P01AG025532-01A1), the Cariparo Foundation and Italian Association for Cancer Research to R.R.; by the Italian Ministry of Education, University and Research, the Cariparo Foundation and the Veneto Region (Biotech 2) to T.P.; by the University of Padova to M.B.; and by: the Italian Association for Cancer Research (AIRC), Telethon (GGP09128), local funds from the University of Ferrara, the Italian Ministry of Education, University and Research (COFIN), the Italian Cystic Fibrosis Research Foundation and Italian Ministry of Health to P.P.
- Pawson T, Nash P: Protein-protein interactions define specificity in signal transduction. Genes Dev. 2000, 14: 1027-1047.PubMedGoogle Scholar
- Shenoy SK, Lefkowitz RJ: Multifaceted roles of beta-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling. Biochem J. 2003, 375: 503-515. 10.1042/BJ20031076.PubMed CentralView ArticlePubMedGoogle Scholar
- Mellor H, Parker PJ: The extended protein kinase C superfamily. Biochem J. 1998, 332 (Pt 2): 281-292.PubMed CentralView ArticlePubMedGoogle Scholar
- Gallo A, Ceolotto G, Pinton P, Iori E, Murphy E, Rutter GA, Rizzuto R, Semplicini A, Avogaro A: Metformin prevents glucose-induced protein kinase C-beta2 activation in human umbilical vein endothelial cells through an antioxidant mechanism. Diabetes. 2005, 54: 1123-1131. 10.2337/diabetes.54.4.1123.View ArticlePubMedGoogle Scholar
- Pinton P, Tsuboi T, Ainscow EK, Pozzan T, Rizzuto R, Rutter GA: Dynamics of glucose-induced membrane recruitment of protein kinase C beta II in living pancreatic islet beta-cells. J Biol Chem. 2002, 277: 37702-37710. 10.1074/jbc.M204478200.View ArticlePubMedGoogle Scholar
- Wehrman TS, Casipit CL, Gewertz NM, Blau HM: Enzymatic detection of protein translocation. Nat Methods. 2005, 2: 521-527. 10.1038/nmeth771.View ArticlePubMedGoogle Scholar
- Pinton P, Rimessi A, Romagnoli A, Prandini A, Rizzuto R: Biosensors for the detection of calcium and pH. Methods Cell Biol. 2007, 80: 297-325.View ArticlePubMedGoogle Scholar
- Marsault R, Murgia M, Pozzan T, Rizzuto R: Domains of high Ca2+ beneath the plasma membrane of living A7r5 cells. EMBO J. 1997, 16: 1575-1581. 10.1093/emboj/16.7.1575.PubMed CentralView ArticlePubMedGoogle Scholar
- Barak LS, Ferguson SS, Zhang J, Caron MG: A beta-arrestin/green fluorescent protein biosensor for detecting G protein-coupled receptor activation. J Biol Chem. 1997, 272: 27497-27500. 10.1074/jbc.272.44.27497.View ArticlePubMedGoogle Scholar
- MacDonald I, Knox KA, Gordon J: Stimulation of human B lymphocytes by phorbol esters reported to be selective in the protein kinase C isoforms they activate. Mol Immunol. 1994, 31: 671-674. 10.1016/0161-5890(94)90176-7.View ArticlePubMedGoogle Scholar
- Brini M, Marsault R, Bastianutto C, Alvarez J, Pozzan T, Rizzuto R: Transfected aequorin in the measurement of cytosolic Ca2+ concentration ([Ca2+]c). A critical evaluation. Journal of Biological Chemistry. 1995, 270: 9896-9903. 10.1074/jbc.270.17.9896.View ArticlePubMedGoogle Scholar
- Carter AA, Hill SJ: Characterization of isoprenaline- and salmeterol-stimulated interactions between beta2-adrenoceptors and beta-arrestin 2 using beta-galactosidase complementation in C2C12 cells. J Pharmacol Exp Ther. 2005, 315: 839-848. 10.1124/jpet.105.088914.View ArticlePubMedGoogle Scholar
- Cassutt KJ, Orsini MJ, Abousleiman M, Colone D, Tang W: Identifying nonselective hits from a homogeneous calcium assay screen. J Biomol Screen. 2007, 12: 285-287. 10.1177/1087057106298538.View ArticlePubMedGoogle Scholar
- Pawson T: Protein modules and signalling networks. Nature. 1995, 373: 573-580. 10.1038/373573a0.View ArticlePubMedGoogle Scholar
- Lowes VL, Ip NY, Wong YH: Integration of signals from receptor tyrosine kinases and G protein-coupled receptors. Neurosignals. 2002, 11: 5-19. 10.1159/000057317.View ArticlePubMedGoogle Scholar
- Williams C, Hill SJ: GPCR signaling: understanding the pathway to successful drug discovery. Methods Mol Biol. 2009, 552: 39-50. 10.1007/978-1-60327-317-6_3.View ArticlePubMedGoogle Scholar
- van der Geer P, Hunter T, Lindberg RA: Receptor protein-tyrosine kinases and their signal transduction pathways. Annu Rev Cell Biol. 1994, 10: 251-337. 10.1146/annurev.cb.10.110194.001343.View ArticlePubMedGoogle Scholar
- Golan M, Schreiber G, Avissar S: Antidepressants, beta-arrestins and GRKs: from regulation of signal desensitization to intracellular multifunctional adaptor functions. Curr Pharm Des. 2009, 15: 1699-1708. 10.2174/138161209788168038.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.